Of the 1418 bladder cancer patients enrolled in the study, three (0.2%) carried a HOXB13 mutation p.G84E (OR = 1.6; 95% CI 0.39–6.35; p = 0.8) (Table 1). This evidence concerns the gene HOXB13 and urinary bladder carcinoma.